<DOC>
	<DOCNO>NCT02317497</DOCNO>
	<brief_summary>Background : Sedation intensive care unit ( ICU ) patient necessary relieve patient pain , anxiety agitation enable mechanical ventilation , diagnostic investigation invasive procedure . While sedation policy shift deep sedation moderate , minimal , even sedation general ICU , optimal sedation cerebrovascular ICU patient unclear controversial . Method : MOderate v DEep Regime NeuroIntensive care SEdation ( MODERNISE ) prospective , randomize , open , two-center trial . Patients acute ischemic stroke , intracerebral hemorrhage subarachnoid hemorrhage need ventilate eligible enrollment . It intend enroll 50 patient per group ( n=100 ) . Patients randomize within 72h admission either moderate sedation define Richmond Agitation Sedation Scale ( RASS ) &gt; = -3 deep sedation define RASS &lt; -3 next 72h , wean sedation aim stepwise fashion group . If reduction sedation feasible , patient remain respective sedation level another 12 hour , sedation reduction try . Patients multimodally monitor systemic cerebral parameter ( latter include bispectral index ( BIS ) monitoring ) . The primary endpoint ICU length stay ( ICU-LOS ) ; secondary endpoint several pre-defined variable ICU course , feasibility sedation level without violation pre-defined safety criterion , pre-defined complication , short- long-term functional outcome mortality . Conclusion : The feasibility , safety benefit moderate oppose deep sedation even acute phase severe cerebrovascular disease need clarify prospective randomize study . Results study might change sedation regime help prevent unwanted effect deep sedation brain-injured patient .</brief_summary>
	<brief_title>Sedation Depth Neurocritical Care</brief_title>
	<detailed_description>Executive Summary Rationale While sedation policy shift deep sedation moderate , minimal , even sedation general ICU , optimal sedation cerebrovascular neuro-ICU ( NICU ) patient unclear controversial . The rationale study analyze potential benefit , feasibility safety moderate oppose deep sedation . Aim hypothesis MODERNISE pilot trial aim investigate safety , feasibility potential benefit moderate vs. deep sedation patient severe ischemic stroke , intracerebral hemorrhage subarachnoid hemorrhage . The primary objective compare moderate sedation deep sedation respect ICU-LOS . Design MODERNISE prospective , randomize , control , outcome observer-blinded , two-center trial . Patients randomize either moderate sedation define RASS ) &gt; = -3 deep sedation define RASS &lt; -3 . Study Outcomes The primary endpoint ICU-LOS . Secondary endpoint ventilation-free ICU-LOS , ventilation duration , sedation duration , complication ( include episodes treatment-demanding increase intracranial pressure ( ICP ) , episodes hypotension , episodes cerebral hypoperfusion , pneumonia , sepsis , ileus , episodes paroxysmal sympathetic hyperactivity ( PSH ) ) , time within sedation goal , demand sedative , demand analgesic , demand vasopressor , score ( RASS , nociception coma scale ( NCS ) , Glasgow Coma Scale ( GCS ) , intensive care delirium screen checklist ( ICDSC ) , confusion assessment method - ICU ( CAM-ICU ) , ICU mortality , in-hospital mortality , modify Rankin Scale ( mRS ) 90 day , PTSD 90 day . Discussion To clarify benefit moderate sedation critical care ventilate stroke patient , randomize multicentre trial clearly need . If two-center pilot trial show difference relevant parameter ICU course give promise safety feasibility result , multi-centre trial may plan basis .</detailed_description>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>1. age 18 year old , either sex , 2. one following confirm admission diagnosis : nontraumatic acute ischemic infarction ( AIS ) nontraumatic intracerebral hemorrhage ( ICH ) nontraumatic subarachnoid hemorrhage ( SAH ) , 3. ventilate expect need artificial ventilation 72h , 4. expect ICULOS 5 day , 5. informed consent legal representative . 1. pregnancy 2. intubation artificial ventilation le 3 day 3. severe adult respiratory distress Syndrome ( ARDS ) 4. severe sepsis 5. systemic disorder demand deep sedation 6. extreme agitation 7. need pharmacological paralysis 8. epileptic state 9. refractory intracranial hypertension 10. participation interventional trial 11. life expectancy &lt; 3 week , poor prognosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Neurocritical care</keyword>
	<keyword>Severe Stroke</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>Intracerebral hemorrhage</keyword>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Sedation</keyword>
	<keyword>RASS</keyword>
	<keyword>BIS</keyword>
</DOC>